<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p16" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_16{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_16{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_16{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_16{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_16{left:128px;bottom:1027px;letter-spacing:-0.18px;}
#t6_16{left:238px;bottom:1027px;letter-spacing:-0.23px;}
#t7_16{left:238px;bottom:999px;letter-spacing:-0.01px;}
#t8_16{left:238px;bottom:979px;letter-spacing:-0.01px;}
#t9_16{left:238px;bottom:960px;letter-spacing:-0.01px;}
#ta_16{left:238px;bottom:906px;letter-spacing:-0.01px;}
#tb_16{left:238px;bottom:887px;letter-spacing:-0.01px;}
#tc_16{left:238px;bottom:852px;letter-spacing:-0.01px;}
#td_16{left:293px;bottom:822px;}
#te_16{left:321px;bottom:823px;letter-spacing:0.21px;}
#tf_16{left:321px;bottom:804px;letter-spacing:0.21px;}
#tg_16{left:293px;bottom:783px;}
#th_16{left:321px;bottom:784px;letter-spacing:0.21px;}
#ti_16{left:238px;bottom:755px;letter-spacing:-0.01px;}
#tj_16{left:238px;bottom:726px;letter-spacing:-0.01px;}
#tk_16{left:238px;bottom:707px;letter-spacing:-0.01px;}
#tl_16{left:128px;bottom:658px;letter-spacing:-0.18px;}
#tm_16{left:238px;bottom:658px;letter-spacing:-0.21px;}
#tn_16{left:238px;bottom:629px;letter-spacing:-0.01px;}
#to_16{left:238px;bottom:610px;letter-spacing:-0.01px;}
#tp_16{left:238px;bottom:590px;letter-spacing:-0.01px;}
#tq_16{left:238px;bottom:536px;letter-spacing:-0.01px;}
#tr_16{left:238px;bottom:517px;letter-spacing:-0.01px;}
#ts_16{left:238px;bottom:495px;letter-spacing:-0.01px;}
#tt_16{left:279px;bottom:495px;letter-spacing:-0.01px;}
#tu_16{left:477px;bottom:495px;letter-spacing:-0.01px;}
#tv_16{left:128px;bottom:438px;letter-spacing:0.16px;}
#tw_16{left:238px;bottom:439px;letter-spacing:-0.19px;}
#tx_16{left:238px;bottom:416px;letter-spacing:-0.01px;}
#ty_16{left:238px;bottom:397px;letter-spacing:-0.01px;}
#tz_16{left:238px;bottom:378px;letter-spacing:-0.01px;}
#t10_16{left:299px;bottom:378px;letter-spacing:-0.01px;}
#t11_16{left:338px;bottom:378px;letter-spacing:-0.01px;}
#t12_16{left:495px;bottom:378px;letter-spacing:-0.01px;}
#t13_16{left:579px;bottom:378px;letter-spacing:-0.01px;}
#t14_16{left:636px;bottom:378px;letter-spacing:-0.01px;}
#t15_16{left:715px;bottom:378px;letter-spacing:-0.01px;}
#t16_16{left:238px;bottom:358px;letter-spacing:-0.01px;}
#t17_16{left:282px;bottom:358px;letter-spacing:-0.01px;}
#t18_16{left:321px;bottom:358px;letter-spacing:-0.01px;}
#t19_16{left:422px;bottom:358px;letter-spacing:-0.01px;}
#t1a_16{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_16{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_16{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_16{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_16{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_16{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_16{font-size:13px;font-family:NotoSans-Regular_7j-;color:#F78C00;}
.s6_16{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts16" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg16Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg16" style="-webkit-user-select: none;"><object width="908" height="1286" data="16/16.svg" type="image/svg+xml" id="pdf16" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_16" class="t s0_16">2.2. Basics of the methodology </span><span id="t2_16" class="t s1_16">16 </span>
<span id="t3_16" class="t s2_16">The aim of situation-appropriate therapy is to improve functional outcomes and thus quality </span>
<span id="t4_16" class="t s2_16">of life, as well as to reduce the toxicity of treatment. </span>
<span id="t5_16" class="t s3_16">2.1.2. </span><span id="t6_16" class="t s3_16">Addressees </span>
<span id="t7_16" class="t s2_16">The target patient group of this guideline are adults in whom there is a suspicion of the </span>
<span id="t8_16" class="t s2_16">presence of a malignant tumor of the larynx due to functional disorders of voice production, </span>
<span id="t9_16" class="t s2_16">breathing or swallowing and those in whom it has already been diagnosed or even treated. </span>
<span id="ta_16" class="t s2_16">The target group of users are practitioners who work in inpatient or outpatient settings </span>
<span id="tb_16" class="t s2_16">(especially ENT doctors and general practitioners). </span>
<span id="tc_16" class="t s2_16">The following professional groups are addressed: </span>
<span id="td_16" class="t s4_16">• </span><span id="te_16" class="t s0_16">Doctors, especially ENT doctors, phoniatrists, radiation oncologists, haemato-oncologists, </span>
<span id="tf_16" class="t s0_16">pathologists, radiologists, maxillofacial surgeons and general practitioners </span>
<span id="tg_16" class="t s4_16">• </span><span id="th_16" class="t s0_16">Speech therapists, psychologists, social workers </span>
<span id="ti_16" class="t s2_16">Other indirect recipients are dentists. </span>
<span id="tj_16" class="t s2_16">In addition, the guideline and its patient guidelines are also aimed at patients, their relatives </span>
<span id="tk_16" class="t s2_16">and interested laypeople. </span>
<span id="tl_16" class="t s3_16">2.1.3. </span><span id="tm_16" class="t s3_16">Period of validity and update procedure </span>
<span id="tn_16" class="t s2_16">The S3 guideline is valid until the next update, the period of validity is estimated at 5 years. </span>
<span id="to_16" class="t s2_16">Regular updates of the entire guideline are planned; if urgent changes are required, individual </span>
<span id="tp_16" class="t s2_16">topics can be updated as part of amendments. </span>
<span id="tq_16" class="t s2_16">Comments and suggestions for the update process are welcome and can be sent to </span>
<span id="tr_16" class="t s2_16">the following address: </span>
<span id="ts_16" class="t s5_16">larynx </span><span id="tt_16" class="t s5_16">carcinoma@leitlinienprogramm- </span><span id="tu_16" class="t s5_16">onkologie.de </span>
<span id="tv_16" class="t s6_16">2.2. </span><span id="tw_16" class="t s6_16">Basics of the methodology </span>
<span id="tx_16" class="t s2_16">The methodological approach to the preparation of the guideline is set out in the guideline </span>
<span id="ty_16" class="t s2_16">report. This is available on the Internet, for example on the website of the Oncology Guideline </span>
<span id="tz_16" class="t s2_16">Program (</span><span id="t10_16" class="t s5_16">http:// </span><span id="t11_16" class="t s5_16">www.leitlinienprogramm- </span><span id="t12_16" class="t s5_16">onkologie.de/ </span><span id="t13_16" class="t s5_16">leitlinien/ </span><span id="t14_16" class="t s5_16">larynxkrebs/ </span><span id="t15_16" class="t s2_16">) and the AWMF </span>
<span id="t16_16" class="t s2_16">pages (</span><span id="t17_16" class="t s5_16">http:// </span><span id="t18_16" class="t s5_16">www.awmf.org/ </span><span id="t19_16" class="t s2_16">) is freely available. </span>
<span id="t1a_16" class="t s0_16">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
